Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Lōvu Health Raises $8Million Series A to Transform Maternal Care
Lōvu Health, a digital platform that supports mothers and babies from the time of conception through the postpartum period, recently raised $8 million in Series A funding. This funding was led by SJF Ventures, with support from other investors such as Rogue Women’s Fund, Symphonic Capital, and Emmeline Ventures. The company is tackling a major issue in the U.S., where almost half of women skip prenatal or postnatal care because of high costs and limited access. Lōvu provides ongoing and connected maternal care, changing how women receive support before and after childbirth.
ConcertAI Appoints Casey Graves to Lead Clinical Solutions
ConcertAI, a well-known company that offers AI-powered and multi-modal data solutions in healthcare and life sciences, has appointed Casey Graves as the new general manager for Clinical Solutions. In this role, Graves will work on promoting the company’s real-world data and AI projects within oncology research and patient care. His main goal is to speed up innovation and provide meaningful results for healthcare professionals and patients by improving cancer research and treatment methods.
Biocon Opens First U.S. Manufacturing Plant in New Jersey
Biocon Limited, a top global biopharmaceutical company listed on BSE and NSE with the ticker BIOCON, has opened its first manufacturing plant in the United States through its wholly owned subsidiary, Biocon Generics Inc. The facility is located in Cranbury, New Jersey. The event to mark its opening was attended by Phil Murphy, the Governor of New Jersey, along with Biocon’s Chairperson Kiran Mazumdar-Shaw, industry experts, partners, and customers.
Inpharmus Expands Global Reach in Rare Diseases and Oncology
Inpharmus is steadily increasing its presence in global healthcare by using its strong knowledge of rare diseases and cancer treatments, along with a team of skilled professionals and a focus on innovation. Right now, the company sells its products in important areas such as the Middle East, Russia, Africa, and Turkey, which are collectively referred to as the MERAT Region. With a clear plan for growth, Inpharmus is aiming to reach $500 million in international sales by 2030.
PurpleLab Grows Healthcare Ads with New Strategic Deals
PurpleLab, the healthcare analytics company powering evidence-based decisions across life sciences, has announced a series of major partnerships with Experian, DeepIntent, InsightsRx, and Comscore. Together, these collaborations allow advertisers to use data in more innovative ways, ensuring advertising ROI.
To share your insights, please write to us at sudipto@intentamplify.com
